RE:RE:My opinion Realitycheck4u, since you've been here for a long while how many times have you thought "just another few months" ? Through the false sales estimates, the new sales team, European approval, F8, IV push, NASH trial starting, NASH partnership coming, Oncology results in 2021, oncology results in early 2022 now, if there is no efficacy to report in part 1 then we wait another 6 months. The only thing this company has been consistently good at is moving on from one failure by creating hope in the next inevitable failure
realitycheck4u wrote:
I understand the frustration. I've been in this too for a long while. However, this does seem different on a substantial level. Paul has said his piece and he said 1st qtr 2022. He has also brought solid plans and is building a team. This could be different. We will see end of March. Patience is still needed here. Not much longer.
Momo25 wrote: I am not a scientist and I don't care about the science per say. I care about the money I have invested in this company when the share was at $15. I am still above 6$ a share in average . TH executives have no clue about the shareholders Return Of Investment. I see some of you trying to justify Paul's and the board attitudes. Those are a gang of losers not business men.